2-Chloro-3-cyclopropoxypyridine

Catalog No.: 
ACMDFW098
CAS No.: 
1243368-75-3
Molecular Formula: 
C8H8ClNO
Molecular Weight: 
169.61
2-Chloro-3-cyclopropoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$155.00InquiryInquiry
1g98%$497.00InquiryInquiry
5g98%$2460.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-3-cyclopropoxypyridine
IUPAC Name2-Chloro-3-cyclopropoxypyridine
Molecular FormulaC8H8ClNO
Molecular Weight169.61
SMILESClC1=NC=CC=C1OC2CC2
InChI KeyONRBALYGOJGSKD-UHFFFAOYSA-N
SynonymPyridine, 2-chloro-3-(cyclopropyloxy)-
CAS No.1243368-75-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMDFW098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAURT104 route compound structure diagram
    ACAURT1046636-78-8In Stock
  4. Then
  5. ACMDFW098 route product structure diagram
    ACMDFW0981243368-75-3
Inquiry

2. ACMDFW098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  2. Plus
  3. ACBAOJ704 route compound structure diagram
    ACBAOJ70416545-68-9In Stock
  4. Then
  5. ACMDFW098 route product structure diagram
    ACMDFW0981243368-75-3
Inquiry

3. ACMDFW098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBAOJ704 route compound structure diagram
    ACBAOJ70416545-68-9In Stock
  2. Plus
  3. ACAURT104 route compound structure diagram
    ACAURT1046636-78-8In Stock
  4. Then
  5. ACMDFW098 route product structure diagram
    ACMDFW0981243368-75-3
Inquiry

Comments (0)